Data Year:

For its 2024 fiscal year, EXACT SCIENCES CORP, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Business Services industry
Jacob Orville
Executive Vice President and General Manager, Screening
Total Compensation $4,433,192 View details Pay Rank By Title In Business Services industry #45 View more
Everett Cunningham
Former Executive Vice President and Former Chief Commercial Officer
Total Compensation $4,141,654 View details Pay Rank By Title In Business Services industry #55 View more
Kevin Conroy
Chairman, President and Chief Executive Officer
Total Compensation $15,539,378 View details Pay Rank By Title In Business Services industry #95 View more
Sarah Condella
Executive Vice President, Human Resources
Total Compensation $2,645,555 View details Pay Rank By Title In Business Services industry #92 View more
Jeffrey Elliott
Former Executive Vice President and Former Chief Financial Officer
Total Compensation $3,221,441 View details Pay Rank By Title In Business Services industry #224 View more
Brian Baranick
Executive Vice President and General Manager, Precision Oncology
Total Compensation $4,399,668 View details Pay Rank By Title In Business Services industry #46 View more
Aaron Bloomer
Executive Vice President and Chief Financial Officer
Total Compensation $7,186,788 View details Pay Rank By Title In Business Services industry #69 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at EXACT SCIENCES CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. EXACT SCIENCES CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. EXACT SCIENCES CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Jacob Orville
Executive Vice President and General Manager, Screening
Total Cash $820,812 Equity $3,581,298 Other $31,082 $4,433,192
Everett Cunningham
Former Executive Vice President and Former Chief Commercial Officer
Total Cash $315,503 Equity $3,820,428 Other $5,723 $4,141,654
Kevin Conroy
Chairman, President and Chief Executive Officer
Total Cash $1,795,697 Equity $13,496,138 Other $247,543 $15,539,378
Sarah Condella
Executive Vice President, Human Resources
Total Cash $676,344 Equity $1,910,213 Other $58,998 $2,645,555
Jeffrey Elliott
Former Executive Vice President and Former Chief Financial Officer
Total Cash $392,176 Equity $273,173 Other $2,556,092 $3,221,441
Brian Baranick
Executive Vice President and General Manager, Precision Oncology
Total Cash $797,380 Equity $3,581,298 Other $20,990 $4,399,668
Aaron Bloomer
Executive Vice President and Chief Financial Officer
Total Cash $1,168,530 Equity $6,002,837 Other $15,421 $7,186,788
For its 2024 fiscal year, EXACT SCIENCES CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Kevin Conroy CEO Pay $15,569,661 Median Employee Pay $142,608 CEO Pay Ratio 109:1
For its 2024 fiscal year, EXACT SCIENCES CORP, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
D. Scott Coward Total Cash $333,892
Daniel Levangie Total Cash $346,392
James Doyle Total Cash $381,392
Katherine Zanotti Total Cash $343,892
Kathleen Sebelius Total Cash $341,392
Michael Barber Total Cash $673,683
Paul Clancy Total Cash $356,392
Shacey Petrovic Total Cash $338,892
Timothy Scannell Total Cash $111,364
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.